Sei Investments Co. Buys 2,756 Shares of National Health Investors, Inc. (NYSE:NHI)

Sei Investments Co. lifted its position in National Health Investors, Inc. (NYSE:NHIFree Report) by 32.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,175 shares of the real estate investment trust’s stock after purchasing an additional 2,756 shares during the quarter. Sei Investments Co.’s holdings in National Health Investors were worth $757,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of NHI. Compass Wealth Management LLC acquired a new stake in shares of National Health Investors in the first quarter valued at approximately $30,000. International Assets Investment Management LLC bought a new position in National Health Investors in the second quarter valued at about $36,000. Blue Trust Inc. increased its position in National Health Investors by 2,651.9% in the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 716 shares during the period. Allspring Global Investments Holdings LLC lifted its position in National Health Investors by 66.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 2,594 shares of the real estate investment trust’s stock valued at $163,000 after purchasing an additional 1,033 shares during the period. Finally, Shayne & Jacobs LLC bought a new position in shares of National Health Investors in the 2nd quarter valued at about $210,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Price Performance

Shares of NYSE NHI opened at $81.11 on Wednesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 10.27 and a quick ratio of 10.27. The business has a 50-day moving average of $79.88 and a 200-day moving average of $70.82. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of 26.59, a PEG ratio of 8.86 and a beta of 1.04. National Health Investors, Inc. has a fifty-two week low of $48.51 and a fifty-two week high of $86.13.

National Health Investors (NYSE:NHIGet Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The company had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. During the same period last year, the firm earned $1.06 EPS. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. As a group, sell-side analysts predict that National Health Investors, Inc. will post 4.55 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Friday, September 27th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.44%. The ex-dividend date is Friday, September 27th. National Health Investors’s dividend payout ratio (DPR) is presently 118.03%.

Wall Street Analyst Weigh In

Several brokerages have commented on NHI. Bank of America assumed coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. StockNews.com raised National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, August 8th. Truist Financial boosted their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. Finally, Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $73.29.

Check Out Our Latest Stock Analysis on NHI

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.